SGLT2 inhibitors and cardioprotection

被引：0

作者：

Chen, S. ^{[1
]}

Wang, Q. ^{[1
]}

Christodoulou, A. ^{[2
]}

Mylonos, N. ^{[2
]}

Bakker, D. ^{[1
]}

Wakker, V. ^{[3
]}

Hollmann, M. W. ^{[1
]}

Weber, N. C. ^{[1
]}

Coronel, R. ^{[4
]}

Christoffels, V. ^{[3
]}

Andreadou, I. ^{[2
]}

Zuurbier, C. J. ^{[1
]}

机构：

[1] Univ Amsterdam, Lab Expt Intens Care & Anesthesiol, Dept Anesthesiol, Amsterdam Cardiovascular Sci,Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[2] Natl & Kapodistrian Univ Athens, Lab Pharmacol, Fac Pharm, Zografou, Athens 15771, Greece

[3] Univ Amsterdam, Dept Med Biol, Amsterdam Cardiovasc Sci, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[4] Univ Amsterdam, Dept Expt Cardiol, Amsterdam Cardiovasc Sci, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

来源：

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2023年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

57ASM - 25

引用

页数：1

共 50 条

[1] SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses
Filippatos, Theodosios D.
Liontos, Angelos
Papakitsou, Ioanna
Elisaf, Moses S.
POSTGRADUATE MEDICINE, 2019, 131 (02) : 82 - 88
[2] The Enigmata of Cardioprotection With SGLT2 Inhibition
Heusch, Gerd
Kleinbongard, Petra
JACC-BASIC TO TRANSLATIONAL SCIENCE, 2025, 10 (01): : 62 - 64
[3] SGLT2 INHIBITORS
Brito, M.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
[4] SGLT2 inhibitors
Dardi, I.
Kouvatsos, T.
Jabbour, S. A.
BIOCHEMICAL PHARMACOLOGY, 2016, 101 : 27 - 39
[5] SGLT2 inhibitors
Steyn, Lynda
SA PHARMACEUTICAL JOURNAL, 2018, 85 (01) : 72 - 75
[6] SGLT2 inhibitors: reviving the sodium-hydrogen exchanger cardioprotection hypothesis?
Arjun, Sapna
Bell, Robert M.
CARDIOVASCULAR RESEARCH, 2019, 115 (10) : 1454 - 1456
[7] Cardioprotection by SGLT2 Inhibitors-Does It All Come Down to Na+?
Trum, Maximilian
Riechel, Johannes
Wagner, Stefan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
[8] Ketoacidosis with SGLT2 Inhibitors
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
[9] SGLT2 inhibitors: are they safe?
Filippas-Ntekouan, Sebastian
Filippatos, Theodosios D.
Elisaf, Moses S.
POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
[10] Development of SGLT1 and SGLT2 inhibitors
Timo Rieg
Volker Vallon
Diabetologia, 2018, 61 : 2079 - 2086

← 1 2 3 4 5 →